(Circulation. 2000;102:2643.)
© 2000 American Heart Association, Inc.
Basic Science Reports |
From the Cardiac Muscle Research Laboratory, Boston University School of Medicine, Boston, Mass (F.R.E., M.A.F., N.V., C.S.A.); Medizinische Universitätsklinik, Würzburg, Germany (H.S., S.N.); and Harvard Medical School, Boston, Mass (J.P.M.). Drs Eberli and Strömer contributed equally to this article.
| Abstract |
|---|
|
|
|---|
Methods and ResultsWe exposed isolated, perfused isovolumic (balloon in left ventricle) rat and rabbit hearts to low-flow ischemia and increased extracellular calcium (from 1.5 to 16 mmol/L) for brief periods. Intracellular calcium was measured by aequorin. Low-flow ischemia resulted in a 270% increase (P<0.05) in diastolic intracellular calcium, a 50% (P<0.05) calcium transient amplitude decrease, and a 52% (P<0.05) slowing of calcium transient decline. Diastolic pressure increased by 6±2 mm Hg (P<0.05), and rate of systolic pressure decay decreased by 65% (P<0.05). Experimentally increasing extracellular calcium doubled both intracellular diastolic calcium and calcium transient amplitude, concomitant with a developed pressure increase; however, there was no increase in ischemic diastolic pressure, slowing of the calcium transient decay, or further slowing of systolic pressure decay. Similarly, after 45 minutes of low-flow ischemia, after diastolic pressure had increased from 8.5±0.6 to 19.7±3.5 mm Hg (P<0.001), intracoronary high-molar calcium chloride infusion increased systolic pressure from 36±4 to 63±11 mm Hg (P<0.001), indicating an increase in intracellular calcium, but it decreased diastolic pressure from 19.7±3.5 to 17.5±3.7 mm Hg (P<0.01). Conversely, EGTA infusion decreased systolic pressure, indicating a decrease in intracellular calcium, but did not decrease diastolic pressure.
ConclusionsWhen calcium availability was experimentally altered during ischemia, there was no alteration in left ventricular diastolic pressure, suggesting that ischemic diastolic dysfunction is not directly mediated by a calcium activated tension.
Key Words: ischemia calcium diastole
| Introduction |
|---|
|
|
|---|
Postulated responsible mechanisms include an increase in intracellular free calcium and consequent elevated diastolic myofilament force production by persistent calcium-activated cross-bridge cycling in diastole. Alternatively, cross-bridges may lock in the rigor state as a result of a decrease in tissue ATP and creatine phosphate (CP) levels or increased ADP levels.2 3 4 The relative role of these 2 mechanisms (calcium-activated tension versus rigor bond formation) in causing ischemic diastolic dysfunction remains controversial. To help resolve this question, we created a state of ischemic diastolic dysfunction in isolated hearts and altered the intracellular calcium level with a brief perturbation, reasoning that ischemic diastolic chamber stiffness, if driven by abnormal calcium-activated tension, should be increased by an increase in [Ca2+]i or decreased by a decrease in [Ca2+]i.
| Methods |
|---|
|
|
|---|
The experiments to examine the effects of calcium perturbations during prolonged low-flow ischemia (perfusion condition and protocols as below) were performed in an isolated, isovolumic, red cellperfused rabbit heart preparation as described previously in detail.5 Hearts of male New Zealand White rabbits were perfused with a red cell perfusate consisting of bovine red blood cells (at a final hematocrit of 40%) in Krebs-Henseleit buffer with 1.0 mmol/L lactate, 0.4 mmol/L palmitic acid, and 40 g/L BSA added. Final ionized calcium concentration was measured by a calcium electrode (NOVA 6, NOVA Biomedical Corp) and adjusted to 1.35 meq/L.
For both buffer-perfused rat hearts and red cellperfused rabbit heart experiments, coronary perfusion pressure (CPP) was monitored via a sidearm of the aortic cannula connected to a pressure transducer (Gould-Statham P23dB, Gould Inc) and recorded continuously on a multichannel physiological recorder (Gould Inc). A collapsed, thin-walled latex balloon was placed in the left ventricle (LV) via the left atrium. The balloon was connected to a pressure transducer to measure LV pressure and its first derivative.
Lactate concentrations in arterial and venous samples were measured with a specific enzymatic technique. At specified time points, rabbit hearts were freeze-clamped, and tissue levels of ATP, CP, and lactate were determined spectrophotometrically.5
All animal handling and procedures strictly adhered to the regulations of Boston University Animal Care and the National Society for Medical Research.
Protocol 1: Aequorin Experiments in Isolated Rat Hearts During
Short Periods of Low-Flow Ischemia
Aequorin Loading
Aequorin was macroinjected with a technique previously described
for the ferret whole-heart preparation and slightly modified for the
intact rat heart.6 7 Briefly, 3 to 5 µL of an
aequorin-containing solution (1 µg/mL) was injected with a glass
micropipette into the interstitium of the inferoapical region of the
LV. The heart was positioned in an organ bath with the aequorin-loaded
area of the LV directed toward the cathode of a photomultiplier (model
9635QA, Thorn-EMI, Gencom, Inc) and submerged in Krebs-Henseleit
solution. The organ bath was enclosed in a light-occlusive photographic
bellows designed for studies with aequorin-loaded
muscles.6 The temperature was increased from 25°C to
37°C within 15 minutes, and the hearts were finally paced at 5
Hz.
Measurement of Intracellular Calcium
Aequorin light signals were recorded on a 4-channel
recorder. At each time point of interest, 20 to 40 light transients
were wave averaged. To compare light values of different experiments
and to compensate for aequorin consumption, the method of fractional
luminescence was used as described previously.7 8 Briefly,
at the end of each experiment, the heart was perfused with a solution
containing 20 mmol/L calcium and 5% Triton X-100 to lyse the
aequorin-loaded cells and expose all the remaining aequorin to calcium.
This resulted in an instantaneous burst of light, subsequently
declining to baseline within 10 to 20 minutes. The area under the curve
was integrated to obtain a value for the total amount of light
(Lmax) emitted from the aequorin loaded into the
myocytes as described by Kihara et al.6 To obtain
Lmax(t) for an individual time point, the
integral of the aequorin signal from the respective time point up to
the end of the experiment was added to Lmax.
Light values of a specific time point were expressed as
L/Lmax(t).
Measurement of Time Constant of LV Pressure Decay and Constant of
Decrease of Intracellular Calcium
In addition to the chart-strip recording, the LV
pressure tracings and light signals were digitized by a 12-bit
analog-to-digital converting board at a sampling rate of 1 kHz (DAP
800/3, Microstar). With the use of custom software, the time constants
of exponential pressure decay (
p) and of light
decrease (
ca) were calculated through the
variable asymptote method.9
Aequorin Protocol
After Aequorin loading and after steady-state conditions were
reached, the intracardiac balloon volume of the rat hearts (n=12) was
set to 50% of Volmax (balloon volume at peak
developed pressure).10 This balloon volume was kept
constant for the remainder of the experiment. Under this condition, an
increase in LV isovolumic diastolic pressure signifies a
decrease in diastolic chamber distensibility.5
After a stabilization period of 20 minutes, coronary flow was
reduced to 5% of the initial value. After 15 minutes, when
ischemic contracture, as defined by an increase in isovolumic
diastolic pressure of >5 mm Hg, had occurred, the
perfusate was switched to a buffer containing 16 mmol/L
Ca2+ in form of CaCl2 fully
equilibrated with identical measured pH. The coronary flow rate
remained constant.
Protocol 2: Effect of Short Periods of Calcium Overload and EGTA
During Prolonged Ischemia Protocols in Rabbit Hearts
Before the protocols described below, all rabbit hearts were
perfused at a constant CPP of 100 mm Hg for 30 minutes. LV
balloon volume was adjusted so that LV isovolumic diastolic
pressure was 10 mm Hg. Hearts were then exposed to 60 minutes of
low-flow ischemia at a constant CPP of 8 mm Hg and
reperfused at initial perfusion conditions, ie, at a constant CPP of
100 mm Hg for 30 minutes. After 5, 15, 30, and 45 minutes of
low-flow ischemia, a control group (n=6) was subjected to a
bolus of 0.08 mL of 0.9% NaCl, a calcium group (calcium constant CPP;
n=6) to a bolus of 0.08 mL of the 260 mmol/L
CaCl2 solution, and a EGTA group (n=6) to 0.08 mL
of a 10-2 mol/L EGTA
solution. Calcium infusion had a small initial vasodilatory effect,
followed by a small vasoconstrictor effect after about 1 minute.
Because this change in coronary blood flow (CBF), even though
minimal, could have affected isovolumic diastolic pressure,
an additional group of hearts (calcium constant CBF; n=7) was exposed
to the bolus of the high-molar calcium chloride solution, with the
system switched from a constant CPP mode to a constant CBF mode during
the intervention and for 5 minutes afterward.
Statistical Analysis
Data are reported as mean±SEM. Data acquired by repeated
sequential measurements in individual hearts were tested by ANOVA for
repeated measures. Comparison between
2 experimental groups was
performed by 2-way ANOVA. Post hoc analysis was performed by
the method of least significant differences. A difference of a single
metabolic measurement between experimental groups within 1
protocol was tested by an unpaired t test. A value of
P<0.05 was considered significant.
| Results |
|---|
|
|
|---|
ca, increased during ischemia but did
not increase significantly further during calcium infusion. The time
constant of pressure decay,
p, increased
during ischemia but decreased after calcium infusion.
|
|
Protocol 2: Effect of Calcium Perturbation During Prolonged
Low-Flow Ischemia
Coronary flows were identical (1.2 to 1.3 mL ·
g-1 ·
min-1) during
preischemia in the 4 groups that underwent the prolonged
ischemia-reperfusion
protocol.
During ischemia, CBF fell comparably in all groups, initially
to 15% to 23% and subsequently to 9% to 12% of baseline. During
reperfusion, an initial hyperemic CBF subsequently returned to
baseline values in all groups. Developed pressure (ie, systolic
minus diastolic pressure) was similar in all groups at
baseline, low-flow ischemia, and reperfusion (Figure 2
).
|
Effects of Calcium Overload
At 5 minutes of ischemia, diastolic pressure
had not yet increased. Increasing
[Ca2+]o, and thereby
increasing [Ca2+]i, had
no effect on diastolic pressure, although it dramatically
increased systolic function (Figure 2
). At 45 minutes of
ischemia, diastolic pressure had increased. A
typical result of a calcium infusion at this time point is given in
Figure 3
. There was a marked positive inotropic effect,
indicating an increase in
[Ca2+]i; however, similar
to the aequorin experiments, LV diastolic pressure
decreased slightly.
|
LV pressure decay, as assessed by maximal negative dP/dt, was not
slowed but rather increased after experimental calcium overload at all
times during ischemia (Figure 4
). This can be explained
by the afterload dependency of maximal negative dP/dt.11
Therefore, we normalized maximal negative dP/dt per developed pressure
to estimate the rate of pressure decay relative to the increase in
afterload. At 45 minutes of ischemia, maximal negative dP/dt
per developed pressure in the calcium constant CPP group was 12.1±1.0
seconds-1 and stayed at
12.4±1.4 seconds-1
(P=NS) after experimental calcium overload. In the calcium
constant CBF group, this value increased from 7.4±1.1 to 11.5±1.3
seconds-1
(P<0.001) after the imposed calcium overload, indicating an
increased rate of LV pressure decay, consistent with the
observed increase in
p after the
calcium bolus in the aequorin experiments.
|
Effects of EGTA
A typical EGTA infusion at 45 minutes of ischemia is shown
in Figure 3
. During ischemia, EGTA decreased
systolic pressure, indicating a decrease in
[Ca2+]i, but did not
decrease LV isovolumic diastolic pressure (Figure 2
). EGTA did decrease maximal negative dP/dt. However, maximal
negative dP/dt per developed pressure was unchanged, eg, 13.0±0.2
seconds-1 before EGTA and
13.0±1.2 seconds-1
(P=NS) after EGTA infusion at 45 minutes of
ischemia.
Metabolic Effects of Ischemia-Reperfusion
During the preischemic period, all hearts used lactate
as substrate and thus showed net lactate uptake or "negative"
production. Low-flow ischemia resulted in a substantial
lactate production in all groups in protocol 2. However, total
lactate production, ie, combined lactate washout during
ischemia and during reperfusion, was the smallest in the EGTA
group (Table 2
).
|
In additional hearts undergoing the same low-flow ischemia
protocol, ATP and CP tissue levels were measured after 35 minutes of
ischemia. ATP and CP tissue levels in the control and calcium
groups were significantly lower than after 30 minutes of normoxic
perfusion (Table 2
). Therefore, at a time when
diastolic chamber stiffness had slightly increased,
high-energy phosphates were decreased 30% to 50%.
At the end of reperfusion in protocol 2, tissue levels of high-energy
phosphates were similarly depleted by
50% compared with
preischemic values in all 4 groups (Table 2
).
| Discussion |
|---|
|
|
|---|
Similarly, during low-flow ischemia, the times required for calcium transient and LV pressure decay were prolonged; additional experimental calcium overload did not further prolong these decays, suggesting that their ischemic prolongation was not due to cytosolic calcium overload, because deliberate experimental worsening of the calcium overload did not lead to further prolongation of either pressure or calcium transient decay.
However, active tension, as reflected by LV developed pressure, was sensitive to the imposed alterations of [Ca2+]i during ischemia, reflecting its calcium-activated basis. Thus, during low-flow ischemia, systolic function changed in parallel with experimental perturbations of [Ca2+]i, but indexes of ischemic diastolic dysfunction were dissociated from changes in [Ca2+]i.
Subendocardial Rigor
The development of rigor in a subendocardial population of
myocytes would explain all the observations of our study. The myocytes
in rigor would increase diastolic pressure in proportion to
their number but would not be responsive to alteration of
perfusate calcium levels; experiments in isolated myocytes have
consistently demonstrated that myocytes in rigor are
inexcitable and incapable of developing contractile
force.12 13 The myocytes not in rigor are contracting
actively and generating phasic LV pressures and are responsive to
perturbations of calcium availability, and those in the epicardium are
generating an observable aequorin calcium transient. Apparently, these
ischemic but contracting myocytes do not contribute a
calcium-activated tension to LV diastolic pressure,
because there was no diastolic pressure increase in
response to a calcium infusion or decrease in response to an EGTA
infusion. The dissociation during low-flow ischemia between
changes in the time constant of calcium decline and the time constant
of the rate of pressure decline, as well as between the
diastolic myocyte calcium levels and isovolumic LV
end-diastolic pressure, reflects the finding that the
epicardial myocytes from which calcium is being measured are not
representative of the changes in calcium and function
of all the regions of myocardium.
Role of ATP Depletion
A subpopulation of cells in rigor would also explain our ATP
results. Studies in intact tissue have shown that rigor develops when
ATP levels fall to
30% of control levels.14 Our
observed decrease in the average myocardial ATP level of 30% to 50%
during ischemia, concomitant with an increase in LV
end-diastolic pressure, is consistent with rigor
formation in the subendocardium, where the decrease in [ATP] would be
greater than the average myocardial decrease.15 16
Metabolic factors might contribute to rigor development at
such modest decreases in ATP. Metabolites of the creatine kinase
reaction, such as a decrease in CP and an increase in ADP, can affect
rigor tension development and stiffness.3 4 Additionally,
moderate decreases in [ATP] can impair relaxation by mechanisms in
addition to rigor. ATP in the millimolar range has a plasticizing
effect to facilitate myofilament relaxation, and its loss can
contribute to diastolic dysfunction.17
Transmural Heterogeneity
Although we did not directly measure transmural gradients of
tension development, calcium transients, or high-energy phosphates in
these experiments, a number of other studies from our laboratory and
others support this explanation of the present results. Several
studies have demonstrated that subendocardial ischemia is more
severe than subepicardial ischemia for a given decrease in
CPP.15 16 Similarly, recent 31P-NMR
studies of isolated hearts subjected to global low-flow
ischemia have identified 2 regions of different degrees of
acidosis, whereby the extent of increase in LV
end-diastolic pressure correlated closely with the size of
the more severely acidotic (presumably subendocardial)
region.18
Ultrastructural studies of isolated rabbit hearts subjected to global low-flow ischemia have shown a marked degree of heterogeneity, with some myocytes in rigor juxtaposed to adjacent cells with near-normal ultrastructure.19 Studies of isolated cardiomyocytes subjected to metabolic inhibition with cyanide have demonstrated a variable time to the onset of rigor, suggesting intrinsic cell-to-cell heterogeneity in sensitivity to ischemic contracture.20 Thus, all these studies support the concept of heterogeneity of ischemia in this isolated heart model.
Role of Calcium
An accumulation of calcium during ischemia or
hypoxia has been demonstrated and is thought to result from a
combination of increased calcium influx, a decrease in calcium efflux,
and a decreased calcium reuptake by the sarcoplasmic reticulum during
diastole. An increase in
[Ca2+]i has been held
responsible by many,6 including us,1 5 as the
cause of the reversible increase in diastolic chamber
stiffness during angina and in experimental ischemia. Increases
in [Ca2+]i during
hypoxia and zero-flow and low-flow ischemia in the
whole heart have supported this hypothesis.14 21 22
Similarly, in isolated myocytes, a rise in
[Ca2+]i preceded the
onset of contracture during hypoxia or metabolic
inhibition of oxidative
phosphorylation.12 23 None of the
techniques to measure
[Ca2+]i directly measure
[Ca2+]i bound to troponin
(or available for binding to troponin), and it is the troponin-bound
calcium that is responsible for calcium-activated tension.
Therefore, none of these studies established a definitive cause-effect
relationship between ischemia-induced changes in
diastolic chamber stiffness and concomitant changes in
[Ca2+]i, and several
reports showed a clear dissociation between an increase in
[Ca2+]i and the onset of
hypoxic or ischemic contracture.24 25 26
Our aequorin experiments are consistent with previous observations showing an increase in [Ca2+]i during ischemia.6 22 However, after the onset of ischemic diastolic chamber stiffness, when we deliberately perturbed [Ca2+]i to be able to relate changes in diastolic chamber stiffness to changes in [Ca2+]i, we did not substantiate a cause-effect relationship between the increased [Ca2+]i and the increases in ischemic diastolic chamber stiffness.
A feature of ischemic diastolic dysfunction
is prolonged LV pressure decay. In our experiments, the calcium
transient decay was prolonged during ischemia in parallel with
LV pressure decay, as previously observed.22 However, when
we experimentally further increased
[Ca2+]i
ca was not further prolonged, and
p shortened. There are several explanations
for this dissociation. First, as discussed above, the aequorin signal
reports the calcium transient from epicardial myocytes, but the LV
pressure wave is determined from the entire myocardium.
Second, the decay of
ca is a function of
[Ca2+]i and calcium
transient amplitude; a decrease in calcium transient amplitude during
low-flow ischemia would be expected to result in an increase in
ca and does not necessarily reflect impaired
cytosolic calcium removal processes.27
| Acknowledgments |
|---|
| Footnotes |
|---|
Received November 19, 1999; revision received June 22, 2000; accepted June 22, 2000.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. E. Reichelt, L. Willems, J. N. Peart, K. J. Ashton, G. P. Matherne, M. R. Blackburn, and J. P. Headrick Heart/Cardiac Muscle: Modulation of ischaemic contracture in mouse hearts: a 'supraphysiological' response to adenosine Exp Physiol, January 1, 2007; 92(1): 175 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Saini and N. S. Dhalla Defective calcium handling in cardiomyocytes isolated from hearts subjected to ischemia-reperfusion Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2260 - H2270. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Spindler, K. Meyer, H. Stromer, A. Leupold, E. Boehm, H. Wagner, and S. Neubauer Creatine kinase-deficient hearts exhibit increased susceptibility to ischemia-reperfusion injury and impaired calcium homeostasis Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1039 - H1045. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Varma, J. P. Morgan, and C. S. Apstein Mechanisms underlying ischemic diastolic dysfunction: relation between rigor, calcium homeostasis, and relaxation rate Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H758 - H771. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Y. Yoo, J. U. Lee, S. H. Kwak, W. M. Im, C. Y. Jeong, S. S. Chung, M. H. Yoon, S. W. Jeong, and J. T. Park Effects of intracoronary calcium chloride on regional oxygen balance and mechanical function in normal and stunned myocardium in dogs Br. J. Anaesth., January 1, 2002; 88(1): 78 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Varma, F. R. Eberli, and C. S. Apstein Left ventricular diastolic dysfunction during demand ischemia: rigor underlies increased stiffness without calcium-mediated tension. Amelioration by glycolytic substrate J. Am. Coll. Cardiol., June 15, 2001; 37(8): 2144 - 2153. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |